Key facts
Market leader
6.5%*
market share in Ukraine among all manufacturers of the medicinal products
16.8%*
market share in Ukraine among domestic manufacturers of the medicinal products
Export
24.6%**

exports amounted
in 2016

more than 350** nomenclature items from the price list
over 20** destinations – sales geography of the medicinal products
Sales
UAH 2.014 bn + 15.1%**
2013
UAH 2.540 bn + 26%**
2014
UAH 3.597 bn + 42%**
2015
UAH 4.652 bn + 29.1%**
2016
352.081 million grn were paid as the taxes and fees in 2016
Product portfolio
>220
product dossiers in the portfolio (based on 131 INNs**)
UP TO 20
new medicinal products are launched on the market annually
The product portfolio covers all therapeutic groups according to ATC classification.
The main focus is on the 6 groups:
  • 1
    R Respiratory system – 21.3%
  • 2
    A Alimentary tract and metabolism – 21.4%
  • 3
    N Nervous system – 12.1%
  • 4
    C Cardiovascular system – 8.9%
  • 5
    J Antiinfectives for systemic use – 6.8%
  • 6
    M Musculo-skeletal system – 6.5%
  • 7
    Other – 23.1%
Investments

Over UAH 2.3** bn
capital investments
over the past 7 years

where UAH 500** million
are the investments
in API manufacturing in Shostka.

almost 470** million grn were allocated for investments in laboratory and production modernization

Staff
1682 employees have a higher education
  • Ukraine 2523 employees
  • Poland 88 employees
  • Russia 76 employees
  • Uzbekistan 72 employees
  • Kazakhstan 55 employees
  • Kirghizia 28 employees
  • Belarus 12 employees
43% men
57% women
Research and development
134 specialists are engaged in research and development;
amongst 18 specialists with academic degree
(15 – Candidates of Science, 3 – Doctors of Science)
  • 131
    products are under development at different stages
  • 72
    amongst 72 products are with new INNs

* in end-user prices, according to Proxima Research data for year 2016.

** according to Farmak internal information.

** INN means International Nonproprietary Name.